 | • レポートコード：QYR9N8112 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・テネクテプラーゼ薬の世界市場規模 ・主要企業別市場シェア ・テネクテプラーゼ薬の世界市場規模：種類別（静脈内投与量、カテーテル内点滴注入量） ・テネクテプラーゼ薬の世界市場規模：用途別（病院、診療所、外来手術センター、その他） ・テネクテプラーゼ薬のアメリカ市場規模（種類別、用途別） ・テネクテプラーゼ薬のヨーロッパ市場規模（種類別、用途別） ・テネクテプラーゼ薬の中国市場規模（種類別、用途別） ・テネクテプラーゼ薬の日本市場規模（種類別、用途別） ・テネクテプラーゼ薬の東南アジア市場規模（種類別、用途別） ・テネクテプラーゼ薬のインド市場規模（種類別、用途別） ・テネクテプラーゼ薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・テネクテプラーゼ薬の世界市場予測（2019年-2025年） ・テネクテプラーゼ薬の地域別市場予測（2019年-2025年） ... |
Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug.It is estimated that North America dominated the global tenecteplase drug market owing to the increasing innovations in clinical practice, myocardial infection, and access to stroke treatment in this region.
In 2018, the global Tenecteplase Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Tenecteplase Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tenecteplase Drugs development in United States, Europe and China.
The key players covered in this study
Merck
Boehringer Ingelheim
Genentech
Emcure Pharmaceuticals
Rewine pharmaceuticals
Hisun
…
Market segment by Type, the product can be split into
Intravenous Dosage
Intracatheter Instillation Dosage
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Tenecteplase Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tenecteplase Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Tenecteplase Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tenecteplase Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous Dosage
1.4.3 Intracatheter Instillation Dosage
1.5 Market by Application
1.5.1 Global Tenecteplase Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Tenecteplase Drugs Market Size
2.2 Tenecteplase Drugs Growth Trends by Regions
2.2.1 Tenecteplase Drugs Market Size by Regions (2014-2025)
2.2.2 Tenecteplase Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Tenecteplase Drugs Market Size by Manufacturers
3.1.1 Global Tenecteplase Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Tenecteplase Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tenecteplase Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tenecteplase Drugs Key Players Head office and Area Served
3.3 Key Players Tenecteplase Drugs Product/Solution/Service
3.4 Date of Enter into Tenecteplase Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Tenecteplase Drugs Market Size by Type (2014-2019)
4.2 Global Tenecteplase Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Tenecteplase Drugs Market Size (2014-2019)
5.2 Tenecteplase Drugs Key Players in United States
5.3 United States Tenecteplase Drugs Market Size by Type
5.4 United States Tenecteplase Drugs Market Size by Application
6 Europe
6.1 Europe Tenecteplase Drugs Market Size (2014-2019)
6.2 Tenecteplase Drugs Key Players in Europe
6.3 Europe Tenecteplase Drugs Market Size by Type
6.4 Europe Tenecteplase Drugs Market Size by Application
7 China
7.1 China Tenecteplase Drugs Market Size (2014-2019)
7.2 Tenecteplase Drugs Key Players in China
7.3 China Tenecteplase Drugs Market Size by Type
7.4 China Tenecteplase Drugs Market Size by Application
8 Japan
8.1 Japan Tenecteplase Drugs Market Size (2014-2019)
8.2 Tenecteplase Drugs Key Players in Japan
8.3 Japan Tenecteplase Drugs Market Size by Type
8.4 Japan Tenecteplase Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Tenecteplase Drugs Market Size (2014-2019)
9.2 Tenecteplase Drugs Key Players in Southeast Asia
9.3 Southeast Asia Tenecteplase Drugs Market Size by Type
9.4 Southeast Asia Tenecteplase Drugs Market Size by Application
10 India
10.1 India Tenecteplase Drugs Market Size (2014-2019)
10.2 Tenecteplase Drugs Key Players in India
10.3 India Tenecteplase Drugs Market Size by Type
10.4 India Tenecteplase Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Tenecteplase Drugs Market Size (2014-2019)
11.2 Tenecteplase Drugs Key Players in Central & South America
11.3 Central & South America Tenecteplase Drugs Market Size by Type
11.4 Central & South America Tenecteplase Drugs Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tenecteplase Drugs Introduction
12.1.4 Merck Revenue in Tenecteplase Drugs Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tenecteplase Drugs Introduction
12.2.4 Boehringer Ingelheim Revenue in Tenecteplase Drugs Business (2014-2019)
12.2.5 Boehringer Ingelheim Recent Development
12.3 Genentech
12.3.1 Genentech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tenecteplase Drugs Introduction
12.3.4 Genentech Revenue in Tenecteplase Drugs Business (2014-2019)
12.3.5 Genentech Recent Development
12.4 Emcure Pharmaceuticals
12.4.1 Emcure Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tenecteplase Drugs Introduction
12.4.4 Emcure Pharmaceuticals Revenue in Tenecteplase Drugs Business (2014-2019)
12.4.5 Emcure Pharmaceuticals Recent Development
12.5 Rewine pharmaceuticals
12.5.1 Rewine pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tenecteplase Drugs Introduction
12.5.4 Rewine pharmaceuticals Revenue in Tenecteplase Drugs Business (2014-2019)
12.5.5 Rewine pharmaceuticals Recent Development
12.6 Hisun
12.6.1 Hisun Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tenecteplase Drugs Introduction
12.6.4 Hisun Revenue in Tenecteplase Drugs Business (2014-2019)
12.6.5 Hisun Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Tenecteplase Drugs Key Market Segments
Table Key Players Tenecteplase Drugs Covered
Table Global Tenecteplase Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tenecteplase Drugs Market Size Market Share by Type 2014-2025
Figure Intravenous Dosage Figures
Table Key Players of Intravenous Dosage
Figure Intracatheter Instillation Dosage Figures
Table Key Players of Intracatheter Instillation Dosage
Table Global Tenecteplase Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Tenecteplase Drugs Report Years Considered
Table Global Tenecteplase Drugs Market Size 2014-2025 (Million US$)
Figure Global Tenecteplase Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tenecteplase Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Tenecteplase Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Tenecteplase Drugs Market Share by Regions 2014-2019
Figure Global Tenecteplase Drugs Market Share by Regions 2014-2019
Figure Global Tenecteplase Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Tenecteplase Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tenecteplase Drugs Market Share by Manufacturers (2014-2019)
Figure Global Tenecteplase Drugs Market Share by Manufacturers in 2018
Table Global Tenecteplase Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tenecteplase Drugs Product/Solution/Service
Table Date of Enter into Tenecteplase Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Tenecteplase Drugs Market Size Share by Type (2014-2019)
Figure Global Tenecteplase Drugs Market Size Market Share by Type (2014-2019)
Table Global Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Tenecteplase Drugs Market Size Share by Application (2014-2019)
Figure Global Tenecteplase Drugs Market Size Market Share by Application (2014-2019)
Figure Global Tenecteplase Drugs Revenue Market Share by Application in 2018
Figure United States Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Tenecteplase Drugs Market Share (2018-2019)
Table United States Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Tenecteplase Drugs Market Share by Type (2014-2019)
Table United States Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Tenecteplase Drugs Market Share by Application (2014-2019)
Figure Europe Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Tenecteplase Drugs Market Share (2018-2019)
Table Europe Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Tenecteplase Drugs Market Share by Type (2014-2019)
Table Europe Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Tenecteplase Drugs Market Share by Application (2014-2019)
Figure China Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Tenecteplase Drugs Market Share (2018-2019)
Table China Tenecteplase Drugs Market Size by Type (2014-20189) (Million US$)
Table China Tenecteplase Drugs Market Share by Type (2014-2019)
Table China Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table China Tenecteplase Drugs Market Share by Application (2014-2019)
Figure Japan Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Tenecteplase Drugs Market Share (2018-2019)
Table Japan Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Tenecteplase Drugs Market Share by Type (2014-2019)
Table Japan Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Tenecteplase Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tenecteplase Drugs Market Share (2018-2019)
Table Southeast Asia Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tenecteplase Drugs Market Share by Type (2014-2019)
Table Southeast Asia Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tenecteplase Drugs Market Share by Application (2014-2019)
Figure India Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Tenecteplase Drugs Market Share (2018-2019)
Table India Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table India Tenecteplase Drugs Market Share by Type (2014-2019)
Table India Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table India Tenecteplase Drugs Market Share by Application (2014-2019)
Figure Central & South America Tenecteplase Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tenecteplase Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tenecteplase Drugs Market Share (2018-2019)
Table Central & South America Tenecteplase Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tenecteplase Drugs Market Share by Type (2014-2019)
Table Central & South America Tenecteplase Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tenecteplase Drugs Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Tenecteplase Drugs Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Tenecteplase Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Genentech Company Details
Table Genentech Revenue in Tenecteplase Drugs Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Genentech Recent Development
Table Emcure Pharmaceuticals Company Details
Table Emcure Pharmaceuticals Revenue in Tenecteplase Drugs Business (2014-2019)(Million US$)
Figure Emcure Pharmaceuticals Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Emcure Pharmaceuticals Recent Development
Table Rewine pharmaceuticals Company Details
Table Rewine pharmaceuticals Revenue in Tenecteplase Drugs Business (2014-2019)(Million US$)
Figure Rewine pharmaceuticals Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Rewine pharmaceuticals Recent Development
Table Hisun Company Details
Table Hisun Revenue in Tenecteplase Drugs Business (2014-2019)(Million US$)
Figure Hisun Revenue Growth Rate in Tenecteplase Drugs Business (2014-2019)
Table Hisun Recent Development
Table Global Tenecteplase Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Tenecteplase Drugs Market Size Share by Regions (2019-2025)
Figure Global Tenecteplase Drugs Market Size Share by Regions in 2025
Figure United States Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tenecteplase Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Tenecteplase Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Tenecteplase Drugs Market Size by Product (2019-2025)
Figure Global Tenecteplase Drugs Market Size by Product in 2025
Table Global Tenecteplase Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Tenecteplase Drugs Market Size by Application (2019-2025)
Figure Global Tenecteplase Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の経口固形製剤受託製造市場：市場規模・現状・予測 In 2018, the global Oral Solid Dosage Contract Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Oral Solid Dosage Contract Manufacturing status, future forecast, growth o…- 世界の経口固形投与製剤市場2019 The global Oral Solid Dosage Pharmaceutical Formulation market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Oral Solid Dosage Pharmaceutical Formulation market status and forecast, categorizes t…
- 世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界のメニエール病の薬市場：市場規模・現状・予測 Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- 世界の凍結乾燥注射薬市場：市場規模・現状・予測 Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period.In 2018, the global Lyophilized Injectable Drugs market size was xx million US$ and it is expected to reach xx million US$ by the …